SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-057833
Filing Date
2019-10-30
Accepted
2019-10-30 16:26:29
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q inva-20190930x10q42cf33.htm   iXBRL 10-Q 1685767
2 EX-10.84 ex-10d84.htm EX-10.84 45986
3 EX-31.1 ex-31d1.htm EX-31.1 12768
4 EX-31.2 ex-31d2.htm EX-31.2 12640
5 EX-32 ex-32.htm EX-32 15670
  Complete submission text file 0001104659-19-057833.txt   6368796

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA inva-20190930.xsd EX-101.SCH 38173
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inva-20190930_cal.xml EX-101.CAL 60624
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inva-20190930_def.xml EX-101.DEF 160093
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20190930_lab.xml EX-101.LAB 372073
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20190930_pre.xml EX-101.PRE 296820
22 EXTRACTED XBRL INSTANCE DOCUMENT inva-20190930x10q42cf33_htm.xml XML 1277715
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 191180553
SIC: 2834 Pharmaceutical Preparations